The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
crane company sees institutional investment growth and analyst upgrades
American Century Companies Inc. increased its stake in Crane Company to 323,272 shares valued at $49 million, while Bank of Nova Scotia entered a new position worth approximately $744,000. Crane operates in three segments: Aerospace & Electronics, Process Flow Technologies, and Engineered Materials, with 75.14% of its stock owned by institutional investors. Recently, UBS upgraded Crane to a "buy" rating with a price target of $190, indicating a potential upside of 28.07%.
casey's general stores insider trading updates and analyst ratings summary
Director Mike Spanos acquired 256 shares of Casey's General Stores, while insider Katrina S. Lindsey sold 250 shares, reducing her stake by 9.28%. Analysts have mixed ratings on the stock, with a consensus of "Moderate Buy" and a price target averaging $430.33. The company recently reported strong earnings, beating estimates with $2.33 EPS and $3.90 billion in revenue.
analysts lower ratings and price targets for kimbell royalty partners
Bank of America lowered its target price on Kimbell Royalty Partners from $16.00 to $14.00, rating it "underperform," while Truist Financial downgraded it from "buy" to "hold" with a new target of $16.00. Mizuho initiated coverage with a "neutral" rating at $16.00. Currently, Kimbell has a consensus "Hold" rating and a price target of $17.40, with institutional investors holding 25.78% of the stock.
excelerate energy reports growth and institutional investment amid market fluctuations
Excelerate Energy, Inc. provides regasification services, LNG terminal services, and natural gas supply for power projects. Recently, JPMorgan Chase & Co. increased its stake in the company, which has a market cap of $2.78 billion and a current stock price of $26.21. Analysts maintain a "Hold" rating, with a consensus price target of $31.17.
director sells shares as health equity insiders reduce positions
Director Robert W. Selander sold 5,750 shares of HealthEquity at $111.29, totaling $639,917.50, reducing his stake by 6.85%. He now owns 78,219 shares valued at $8.7 million. Over the past ninety days, insiders sold 20,381 shares worth $1.78 million, with 2.20% of the stock held by insiders. Barclays PLC increased its stake in HealthEquity by 20.3%, owning 200,341 shares valued at $19.2 million. The stock has a market cap of $7.31 billion, with a current price of $84.52 and a consensus "Buy" rating from analysts.
cannae holdings experiences significant stake changes and stock performance updates
Cannae Holdings, Inc., founded in 2014 and based in Las Vegas, primarily invests in sectors like restaurants and healthcare, taking both minority and majority stakes. Recently, JPMorgan Chase & Co. reduced its stake by 45%, while other investors have made significant changes to their positions. The company has a market cap of $1.09 billion, a P/E ratio of -3.60, and recently declared a quarterly dividend of $0.12 per share, reflecting a yield of 2.77%.
cadre holdings reports earnings miss and announces dividend increase
Cadre Holdings, Inc. manufactures safety equipment, including body armor and bomb suits, with corporate insiders owning 37% of the stock. The company reported a quarterly revenue of $175.98 million, exceeding estimates, but earnings per share fell short at $0.32. Recently, Cadre increased its quarterly dividend to $0.095, and CEO Warren B. Kanders sold 50,000 shares, reducing his ownership slightly.
institutional investors significantly increase stakes in fifth third bancorp
PL Capital Advisors LLC significantly increased its stake in Fifth Third Bancorp by 4,128% in Q4, now holding 1.86 million shares valued at $78.65 million. Other institutional investors, including Jupiter Asset Management and First Trust Advisors, also expanded their positions, with 83.79% of the stock owned by such entities. Analysts have mixed ratings on the stock, with a lowered price target from JPMorgan Chase to $42, while the average target stands at $47.65.
us bancorp insider trades and institutional investments update
U.S. Bancorp's EVP James L. Chosy sold 21,451 shares at $47.65, marking a 9.77% decrease in ownership, while insiders sold a total of 219,812 shares valued at $10.4 million in the last ninety days. Institutional investors now hold 77.60% of the stock, with recent significant purchases from Norges Bank and Invesco Ltd. Analysts maintain a "Moderate Buy" rating, but JPMorgan Chase & Co. has reaffirmed an "underweight" rating with a reduced price target of $43.50.
moelis and company announces dividend increase amid mixed analyst ratings
Moelis & Company declared a quarterly dividend of $0.65 per share, marking an increase from the previous $0.60, with a yield of 4.92%. Analysts have mixed ratings on the stock, with a consensus "Hold" rating and a price target averaging $71.83. Recent insider sales and institutional ownership stand at 91.53%.